582 related articles for article (PubMed ID: 19291526)
21. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
22. Cancer, thrombosis and heparin-induced thrombocytopenia.
Prandoni P; Falanga A; Piccioli A
Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
[TBL] [Abstract][Full Text] [Related]
23. The link between cancer and venous thromboembolism: a review.
Kessler CM
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S3-7. PubMed ID: 19654481
[TBL] [Abstract][Full Text] [Related]
24. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
[TBL] [Abstract][Full Text] [Related]
25. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
26. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
[TBL] [Abstract][Full Text] [Related]
27. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
28. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
29. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
[TBL] [Abstract][Full Text] [Related]
30. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
31. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
Connolly GC; Khorana AA
Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
33. VTE in patients with cancer--diagnosis, prevention, and treatment.
Lee A
Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
[TBL] [Abstract][Full Text] [Related]
34. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
36. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
37. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
38. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism and pancreatic cancer: incidence, pathogenesis and clinical implications.
Mandalà M; Moro C; Labianca R
Onkologie; 2008 Mar; 31(3):129-35. PubMed ID: 18322417
[TBL] [Abstract][Full Text] [Related]
40. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
